牛保健市場規模、佔有率和成長分析：按產品類型、疾病類型、動物種類、分銷管道、最終用戶和地區分類－2026年至2033年產業預測

2024 年全球牛保健市場價值 89 億美元，預計到 2025 年將成長至 93.5 億美元，到 2033 年將成長至 139.3 億美元，在預測期（2026-2033 年）內複合年成長率為 5.1%。

受人口成長和收入提高推動的動物性蛋白質需求激增的驅動，全球牛保健市場正經歷快速成長。隨著消費者越來越重視更高品質的肉類和牛奶，畜牧養殖戶正在採用先進的保健解決方案來維護牛健康並提高生產力。隨著通用感染疾病的增加，透過疫苗、藥物和定期健康檢查進行有效的疾病控制至關重要，這既能保障動物福利，又能確保食品安全。穿戴式感測器和遠端醫療等技術進步正在透過改進監測和疾病檢測來革新牛保健，從而實現個人化治療和有效的畜群管理。然而，挑戰依然存在，包括獸醫服務和產品的高成本、合格獸醫的短缺以及監管障礙，這些障礙對貧困地區的養殖戶影響尤其顯著。

全球牛保健市場的成長要素

全球牛健康保健市場正受到精準農業、穿戴式生物感測器和人工智慧 (AI) 健康監測系統等技術進步的推動。這些創新不僅能夠實現疾病的早期檢測和生命徵象的持續監測，還有助於最佳化飼養和繁殖管理，從而提高牛的健康和生產力。遠端醫療和數位病歷管理的整合提高了獸醫服務的可近性，並支持了知情決策。此外，疫苗研發、基因篩檢和藥物傳遞方法的突破性進展確保了牛的治療效果更佳，降低了發病率和死亡率，並增加了全球對先進獸醫解決方案的需求。

全球牛保健市場面臨的限制因素

全球牛健康保健市場面臨基礎設施不足的嚴峻挑戰。獸醫診所匱乏、疫苗低溫運輸儲存不完善以及運輸系統不可靠，阻礙了基本獸醫服務的提供，尤其是在偏遠和醫療資源匱乏的地區。許多農村地區難以獲得獸醫用品、診斷設備和專業服務，導致在動物健康危機發生時難以及時獲得援助。此外，網路連線不良也限制了先進監測系統和遠端醫療。這些物流和基礎設施方面的不足阻礙了創新牛健康保健解決方案的推廣，並成為市場成長和發展的主要障礙。

全球牛保健市場趨勢

全球牛保健市場正經歷著向預防醫學的顯著轉變，這主要得益於人們對牲畜疾病經濟影響的認知不斷提高。養殖戶們正逐漸摒棄被動治療，轉而優先採用疫苗接種和營養增強免疫力的方法來提升牛群健康。這一趨勢體現了一種注重永續性和成本效益的綜合性牛管理方法。隨著牛呼吸道疾病等疾病的蔓延持續影響生產力，人們對預防性解決方案的依賴性日益增強。因此，對先進疫苗組合和健康管理策略的需求不斷成長，從而改變了牛保健的格局。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 價值鏈分析
• 價格分析
• 案例研究
• 監理情勢
• 技術評估

全球牛保健市場規模：依產品類型分類

• 製藥
  • 疫苗
  • 抗生素
  • 抗發炎藥
  • 殺蟲劑
  • 其他
• 飼料添加劑
  • 維生素和礦物質
  • 胺基酸
  • 益生菌
  • 酵素
  • 其他
• 診斷
  • 免疫診斷
  • 分子診斷
  • 臨床化學
  • 其他
• 醫療器材與設備
  • 手術器械
  • 監控設備
  • 醫療影像設備
  • 其他

全球牛保健市場規模：依疾病類型分類

• 感染疾病
• 寄生蟲病
• 代謝性疾病
• 生殖障礙
• 乳腺炎
• 呼吸系統疾病
• 其他

全球牛保健市場規模：以動物類型分類

• 牛
• 牛
• 牛

全球牛保健市場規模：按分銷管道分類

• 獸醫醫院和診所
• 零售藥房
• 線上管道
• 直銷
• 其他

全球牛保健市場規模：依最終用戶分類

• 酪農
• 牛
• 獸醫醫療機構
• 其他

全球牛保健市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis Inc.
• Merck & Co., Inc.
• Elanco Animal Health Incorporated
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Virbac
• Vetoquinol SA
• Phibro Animal Health Corporation
• Neogen Corporation
• IDEXX Laboratories, Inc.
• HIPRA
• Indian Immunologicals Limited
• Hester Biosciences Limited
• Intas Pharmaceuticals Ltd.
• Zydus Lifesciences Limited
• Bimeda Holdings PLC
• Dechra Pharmaceuticals PLC
• Kyoritsu Seiyaku Corporation
• Norbrook Laboratories Ltd.
• SeQuent Scientific Limited

結論與建議

Global Cattle Healthcare Market size was valued at USD 8.9 billion in 2024 and is poised to grow from USD 9.35 billion in 2025 to USD 13.93 billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The global cattle healthcare market is experiencing rapid growth, driven by the surging demand for animal protein fueled by population growth and increasing incomes. As consumers prioritize higher quality meat and milk, livestock producers are adopting advanced healthcare solutions to maintain herd health and enhance productivity. The rise of zoonotic diseases necessitates robust disease management via vaccines, medications, and routine health assessments, which ensure both animal welfare and food safety. Technological advancements, such as wearable sensors and telemedicine, are revolutionizing cattle healthcare through improved monitoring and disease detection, enabling customized treatment and effective herd management. However, challenges remain due to high costs of veterinary services and products, a shortage of qualified veterinarians, and regulatory hurdles, particularly impacting farmers in impoverished regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cattle Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cattle Healthcare Market Segments Analysis

Global Cattle Healthcare Market is segmented by Product Type, Disease Type, Animal Type, Distribution Channel, End User and region. Based on Product Type, the market is segmented into Pharmaceuticals, Feed Additives, Diagnostics and Medical Devices & Equipment. Based on Disease Type, the market is segmented into Infectious Diseases, Parasitic Diseases, Metabolic Disorders, Reproductive Disorders, Mastitis, Respiratory Diseases and Others. Based on Animal Type, the market is segmented into Dairy Cattle, Beef Cattle and Calves. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Channels, Direct Sales and Others. Based on End User, the market is segmented into Dairy Farms, Cattle Farms, Veterinary Institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cattle Healthcare Market

The global Cattle Healthcare market is being significantly driven by advancements in technology such as precision livestock farming, wearable biosensors, and artificial intelligence-powered health monitoring systems. These innovations facilitate early disease detection and continuous monitoring of vital signs, alongside optimizing feeding and breeding practices, thereby improving herd health and productivity. The integration of telemedicine with digital record-keeping enhances veterinary accessibility and aids in informed decision-making. Furthermore, breakthroughs in vaccine development, genetic screening, and drug delivery methods ensure more effective treatments for cattle, reducing morbidity and mortality rates, and fostering a greater demand for advanced veterinary solutions worldwide.

Restraints in the Global Cattle Healthcare Market

The Global Cattle Healthcare market faces significant challenges due to inadequate infrastructure. The lack of veterinary clinics, proper cold chain storage for vaccines, and reliable transportation systems hinders the delivery of essential veterinary care, particularly in remote and underserved regions. Many rural communities struggle with accessing veterinary supplies, diagnostics, and professional services, complicating timely support during animal health crises. Furthermore, poor internet connectivity restricts the implementation of advanced monitoring systems and telemedicine. These logistical and infrastructural deficiencies contribute to the limited adoption of innovative cattle healthcare solutions, acting as a primary obstacle to market growth and development.

Market Trends of the Global Cattle Healthcare Market

The Global Cattle Healthcare market is witnessing a significant shift towards preventive health measures, driven by an increasing awareness of the economic implications of livestock diseases. Farmers are prioritizing vaccination and nutrition-based immunity enhancers to bolster herd health, moving away from reactive treatments. This trend reflects a holistic approach to cattle management, emphasizing sustainability and cost-effectiveness. As the prevalence of diseases, such as Bovine Respiratory Disease, continues to impact productivity, there is a growing reliance on preventive solutions. Consequently, demand for advanced vaccine portfolios and health management strategies is on the rise, reshaping the landscape of cattle healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Cattle Healthcare Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
  • Vaccines
  • Antibiotics
  • Anti-inflammatory Drugs
  • Parasiticides
  • Others
• Feed Additives
  • Vitamins & Minerals
  • Amino Acids
  • Probiotics
  • Enzymes
  • Others
• Diagnostics
  • Immunodiagnostics
  • Molecular Diagnostics
  • Clinical Chemistry
  • Others
• Medical Devices & Equipment
  • Surgical Instruments
  • Monitoring Devices
  • Imaging Equipment
  • Others

Global Cattle Healthcare Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Infectious Diseases
• Parasitic Diseases
• Metabolic Disorders
• Reproductive Disorders
• Mastitis
• Respiratory Diseases
• Others

Global Cattle Healthcare Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dairy Cattle
• Beef Cattle
• Calves

Global Cattle Healthcare Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Channels
• Direct Sales
• Others

Global Cattle Healthcare Market Size by End User & CAGR (2026-2033)

• Market Overview
• Dairy Farms
• Cattle Farms
• Veterinary Institutions
• Others

Global Cattle Healthcare Market Size & CAGR (2026-2033)

• North America (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda Holdings PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeQuent Scientific Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations